Effect of iron and vitamin C co-supplementation in hyperthyroidism patients
- Conditions
- Condition 1: Hyperthyroidism. Condition 2: Iron deficiency anemia.Thyrotoxicosis [hyperthyroidism]Iron deficiency anemia
- Registration Number
- IRCT20090822002365N27
- Lead Sponsor
- Iran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 80
Men and women over 18 years of age with newly diagnosed hyperthyroidism
Body mass index18.5-30 kg / m2
Hemoglobin level less than 12.7 g / dl for women and less than 13 g / dl for men
Start a medication program
No autoimmune diseases and chronic diseases such as diabetes, hypertension, kidney, liver, gallbladder, thyroid, parathyroid, bone, gastrointestinal and hyperphosphatemia disorders
No infectious diseases, malignancies and severe bleeding in the last 2 months
No thalassemia and other blood disorders
Do not use hormonal drugs, anticonvulsants, cholesterol and fat lowering drugs, antacids, blood thinners, and laxatives.
Do not take iron and vitamin C supplements during the last month
No history of other thyroid disorders
In the case of women, the absence of abnormal and irregular menstrual cycles
No pregnancy and lactation
Willingness to cooperate
Having any acute illness
Changes in medications
Non-regular use of supplements and acceptance rate less than 90%
Migration
Exclusion based on personal preference of participants
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Thyroid stimulating hormone. Timepoint: Before intervention and 8 weeks after intervention. Method of measurement: The level of TSH in serum is with ELISA method.
- Secondary Outcome Measures
Name Time Method